Denise Heady

UCLA & @parkerici collaborators engineered “supercharged” T cells that latch onto prostate cancer like a fishhook, making them stronger, longer lasting & more precise. Findings can lead to safer, more effective T cell therapies for prostate cancer. bit.ly/4cZcbte

UCLA gastroenterologist Folasade May discusses rising colorectal cancer rates among young adults and a public awareness display at UCLA. newsroom.ucla.edu/in-the-news/uc…

A new UCLA study published in @JAMANetworkOpen found that a personalized counseling program can significantly help women who have survived cervical precancer or cervical cancer to quit smoking. bit.ly/4b7rzlW

@PSWnano @uclachem @UCLA One of the best offices I've seen on campus!

Here is a short video of my @uclachem office, part of a series @UCLA. Too bad it was recorded before the quarter, or it would be filled with my amazing honors freshmen, now preparing for their final exam. #chemistry #nano

Thanks @ABC7 for covering this important event and helping raise awareness about the rising risk of colorectal cancer in people under 50.

New study published today in @TheLancet & presented at #ASCOGU26 by @AmarUKishan found that adding hormone therapy to post-operative radiotherapy may provide little survival benefit for most men with prostate cancer. bit.ly/3ZYBN1u

Mineral sunscreen without the chalky look? New research led by @PSWnano & @ajiswriting shows a novel zinc oxide shape reduces white cast, especially for people with darker skin tones. @ACSPublications bit.ly/4qWCowm

Exemplifying excellence in brain cancer research: A conversation with Tim Cloughesy and David A. Nathanson. ow.ly/uKKs50Y0Pv5 #NuclearMedicine #MolecularImaging #BrainCancer

Our Cancer Center Director, Dr. Mike Teitell, reflects on his journey as a physician–scientist in a Q&A w/Dr. Johannes Czernin in this issue of @JournalofNucMed. A thoughtful conversation on discovery, mentorship & the mission of academic cancer centers. bit.ly/49E1VEl

Building on more than a decade of innovation that has made UCLA a global leader in molecular imaging & targeted radiopharmaceutical therapy, UCLA Health has established the Department of Nuclear Medicine and Theranostics — the first of its kind in the U.S. bit.ly/47TgLVq

Do all breast cancer survivors need to see a cardiologist? In a new @JAMAOnc editorial, Dr. Patricia Ganz and Dr. Eric Yang (@datsunian) break down which survivors may benefit most from heart screening and how age and overall heart health shape risk. bit.ly/47VjUFv

Indeed! Mammograms for our healthy 80 year olds are important. Thank you @HemOncToday @UCLAHealth @UCLAHealthJCCC for highlighting our work.

A team of researchers led by @davidulmert has identified a promising new treatment strategy that can detect, kill & reprogram aggressive, treatment-resistant tumors like osteosarcomas & glioblastoma. bit.ly/3VZychI

Just in from #ASTRO25: @AmarUKishan & @CalaisJeremie report adding PSMA-targeted radioligand therapy before SBRT more than doubled progression-free survival in men with recurrent prostate cancer (17.6 vs 7.4 months), delaying the need for hormone therapy. bit.ly/4mAuZzV

A new UCLA study led by @DrNimmiKapoor & published in @AnnSurgOncol found that women in their 80s who get regular mammograms are more likely to have breast cancer detected early, need less aggressive treatment, and live longer. Read more: bit.ly/4mEubKE

The study found pembrolizumab shrank or eliminated tumors in nearly 90% of participants with desmoplastic melanoma that cannot be surgically removed. @UCLAHealthJCCC newsroom.ucla.edu/stories/immuno…

“We have made amazing breakthroughs that are transformative…and that has all come to a screeching halt.”  Following the federal government's suspension of UCLA’s research funding, Prof. David Shackelford speaks with @CNN about what’s at stake. youtube.com/watch?v=W64VZ5…

Blood tests offer a convenient way to screen for colorectal cancer, but a new UCLA study in @AGA_Gastro led by @drfolamay & @Timothy_A_Zaki found only 49% of patients got the critical follow-up colonoscopy within 6 months after an abnormal result. bit.ly/45qyJi7

@montypal @cityofhope Two of my favorite COH docs!

A true legend in the field of hematology/oncology. Dr. Stephen Forman was involved in the seminal studies of BMT for hematologic malignancies & evolved into a pioneer of CAR-T cell therapy. There are literally dozens of faculty at @cityofhope & beyond who consider him to be their most influential mentor. This podcast is a must-listen! @TDorffOnc @SaulPriceman @ArmenianSaro @stacywgray

Growing up in Alaska, Dr. David Nathanson (@NathansonLab) dreamed of being a bush pilot. A chance meeting on a fishing trip changed everything and led him to UCLA, where he's now pioneering new therapies for glioblastoma. Read more about his journey: bit.ly/4eQbEbM